This FOXP4 downregulation‐induced squamous differentiation was regulated through an ELF3‐dependent pathway, suggesting that FOXP4 is a target molecule for differentiation therapy of CIN.11 Here, FOXP4 is linked to cervical squamous intraepithelial neoplasia.